Post-IPO Equity - iBio
Investment Firm
Overview
iBio is a technology platform that develops pharmaceutical product applications.
Announced Date
Mar 26, 2024
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
iBio raised $15000000 on 2024-03-26 in Post-IPO Equity
iBio is a technology platform that develops pharmaceutical product applications.
Company Funding History
6
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 26, 2024 |  Post-IPO Equity - iBio | 3 | - | 15.0M |
| Feb 10, 2016 | Post-IPO Equity - iBio | - | 2.2M | |
| Sep 22, 2009 | Post-IPO Equity - iBio | - | 3.0M | |
| Nov 13, 2010 | Post-IPO Equity - iBio | - | 7.1M |
Recent Activity
There is no recent news or activity for this profile.